2024 - Passed
Louisiana S.B. 224
  • Directs that the state Medicaid program may not impose more restrictive utilization controls for non-opioid drugs than for opioids.
  • Prohibits Medicaid managed care organizations from denying coverage for a non-opioid prescription prescribed for pain in favor of an opioid.
  • Directs the state to create education, awareness and technical assistance materials on the advantage of non-opioid drugs and provide assistance with grants that promote non-opioid pain drugs.
EducationMedicaid Parity
Read Bill
2024 - Passed
Maine L.D. 2096
  • Requires health insurers develop and submit a plan to the Maine Bureau of Insurance for review and approval of the inclusion of non-opioid pain management services and treatments. Upon approval, insurers must develop and disseminate related educational materials.
State Regulated Commercial ParityEducation
Read Bill
2025 - Introduced
Maryland H.B. 1013/S.B. 974
  • Prohibits prior authorization requirements, step therapy protocol, or fail-first protocol for a non-opioid that is more restrictive than requirements for an opioid.
Medicaid ParityState Regulated Commercial Parity
Read House BillRead Senate Bill
2025 - Introduced
Massachusetts H.1134/S.863
  • Mandates Medicaid from imposing restrictive practices that disadvantage or discourage the use of non-opioid drugs for the treatment of pain relative to opioid drugs. The bill also creates a comprehensive integrated care management strategy for chronic pain patients enrolled in Medicaid and requires the Center for Health Information & Analysis to issue a report every two years on the incidence and prevalence of chronic pain in Massachusetts.
Medicaid Parity
Read House BillRead Senate Bill
2024 - Passed
Massachusetts H.5142
  • Requires health insurers to cover non-opioid medications without favoring opioids over non-opioids.
  • Requires the Massachusetts Department of Health create educational materials about non-opioid treatments for use at pharmacies, as well as develop new provider training requirements regarding non-opioid alternatives for pain treatment.
State Regulated Commercial ParityProvider Education
Read Bill
2025 - Introduced
Minnesota S.F. 1946
  • Requires health insurers cover non-opioid treatments and prohibits utilization controls that are more restrictive or extensive than the least restrictive or extensive utilization controls for opioids. Also requires health insurers to distribute non-opioid educational materials to in-network providers and enrollees and to publish resources on the health plan company's website.
State Regulated Commercial ParityProvider Education
Read Bill
2025 - Introduced
Minnesota S.F. 1947
  • Requires that in establishing and maintaining Minnesota's preferred drug list, health insurers must not disadvantage or discourage a non-opioid drug with respect to coverage of an opioid drug.
Medicaid Parity
Read Bill
2025 - Introduced
Mississippi H.B.1389
  • Prohibits practices that disadvantage or discourage the use of non-opioid drugs relative to opioids in state Medicaid program.
Medicaid Parity
Read Bill
2025 - Introduced
Missouri S.B.158
  • For enrollees with an increased risk of opioid abuse, prohibits health insurers from: (1) denying coverage for non-opioid prescription drugs in favor of opioid drugs; (2) requiring an enrollee try an opioid prescription drug prior to approving the use of a non-opioid prescription drug; or (3) requiring a higher cost-sharing for non-opioid prescription drugs.
State Regulated Commercial Parity
Read Bill
2025 - Introduced
Montana H.B. 774
  • Prohibits Medicaid and health insurers from denying coverage of a non-opioid in favor of an opioid and requires that in establishing a drug formulary, the Montana Department of Public Health and Human Services must ensure a non-opioid is not disadvantaged or discouraged as compared to coverage of an opioid.
Medicaid ParityState Regulated Commercial Parity
Read Bill
2025 - Introduced
Nebraska L.B.252 
  • Prohibits Medicaid and health insurers from imposing restrictive practices that disadvantage or discourage the use of non-opioid drugs for the treatment of pain relative to opioid drugs.
Medicaid ParityState Regulated Commercial Parity
Read Bill
2025 - Introduced
Nevada S.B. 377
  • Requires health insurers and Medicaid cover at least one alternative to an opioid and prohibits insurers from requiring prior authorization or other restrictive requirements for an alternative to an opioid compared to requirements established for an opioid.
Medicaid ParityState Regulated Commercial Parity
Read Bill